Absci Corporation (ABSI)
Absci Corporation
18105 SE Mill Plain Boulevard
Vancouver, WA 98683
United States
360 949 1041
https://www.absci.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 155
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Sean McClain | Founder, CEO, President & Director | 1.01M | N/D | 1990 |
| Dr. Zachariah Jonasson Ph.D. | Chief Business Officer & CFO | 331.64k | N/D | 1973 |
| Dr. Andreas Busch Ph.D. | Chief Innovation Officer & Member of Scientific Advisory Board | 1.13M | N/D | 1963 |
| Mr. Todd Bedrick CPA | Senior VP & Chief Accounting Officer | N/D | N/D | N/D |
| Mr. Alexander Khan CPA | VP of Finance & Head of Investor Relations | N/D | N/D | N/D |
| Ms. Karin Wierinck | Chief People Officer | N/D | N/D | N/D |
| Melissa Patterson Ph.D. | Chief of Staff | N/D | N/D | N/D |
| Jens Plassmeier Ph.D. | Senior VP of Biologics Discovery Technology | N/D | N/D | N/D |
| Mr. Wen Sha | Chief of Staff | N/D | N/D | N/D |
| Dr. Christine Lemke D.V.M., M.B.A., Ph.D. | Senior Vice President of Portfolio & Growth Strategy | N/D | N/D | N/D |
Descripción
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Gestión corporativa
La calificación ISS Governance QuickScore de Absci Corporation a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
